Genetic Insights from Feline Cancer Research Could Inform Human Treatments

A recent large-scale analysis has revealed significant genetic changes in various cancer types affecting domestic cats, potentially guiding new treatment strategies for both felines and humans. Conducted by researchers from the Wellcome Sanger Institute, the Ontario Veterinary College in Canada, and the University of Bern, the study examined tumors from nearly 500 pet cats across five countries. Published in the journal *Science*, this research represents the first comprehensive mapping of cat cancer genomics, providing an open resource for future studies.

Science Daily

The study identified key genetic alterations in feline cancers that closely resemble those found in human cancers. Notably, the research highlighted the similarities between feline mammary carcinoma and human breast cancer. The team screened around 1,000 genes associated with human cancer, discovering that several genetic drivers of cancer in cats matched those in humans. For instance, the FBXW7 gene was altered in over 50% of the tumors studied, a mutation linked to poorer outcomes in human breast cancer as well. Additionally, the PIK3CA gene was present in 47% of feline mammary tumors, mirroring its known role in human breast cancer and its targeting by specific drugs.

Science Daily

The findings suggest a promising 'One Medicine' approach, which advocates for collaboration between human and veterinary medicine. This strategy could allow for the testing of effective treatments in both species, fostering advancements in cancer research. Bailey Francis, co-first author at the Wellcome Sanger Institute, emphasized the benefits of cross-species comparisons, stating, "By comparing cancer genomics across different species, we gain a greater understanding of what causes cancer."

Science Daily

Despite the promising results, the study's findings are based on laboratory-grown tissue and require further validation through clinical trials. Critics may point out the need for caution in translating these findings directly to human treatments without extensive testing. Nonetheless, the research marks a significant step towards precision oncology for cats, aiming to match the diagnostic and therapeutic options available for dogs and humans.

Science Daily

Dr. Louise Van Der Weyden, senior author at the Wellcome Sanger Institute, remarked, "This is one of the biggest ever developments in feline oncology and means the genetics of domestic cat tumors are no longer a 'black box'." Professor Geoffrey Wood from the Ontario Veterinary College noted the importance of understanding environmental factors that influence cancer risk in both cats and humans.

Science Daily

The study opens avenues for future research into the genetic basis of cancer in cats and its implications for human health. Researchers hope to explore potential novel therapeutic options that could benefit both species, ultimately enhancing cancer treatment strategies.

Science Daily

• “Researchers Highlight Cross-Species Benefits Bailey Francis, co-first author at the Wellcome Sanger Institute, said: "By comparing cancer genomics across different species, we gain a greater understanding of what causes cancer.” — Bailey Francis, Co-first Author, Wellcome Sanger Institute

Science Daily

• “ Dr Louise Van Der Weyden, senior author at the Wellcome Sanger Institute, said: "This is one of the biggest ever developments in feline oncology and means the genetics of domestic cat tumors are no longer a 'black box'.” — Dr. Louise Van Der Weyden, Senior Author, Wellcome Sanger Institute

Science Daily

• “ Professor Geoffrey Wood, co-senior author at the Ontario Veterinary College, Canada, said: "Despite domestic cats being common pets, there was very little known about the genetics of cancer in these animals, until now.” — Professor Geoffrey Wood, Co-senior Author, Ontario Veterinary College

Science Daily